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A report on the 44th Annual Drosophila Research
Conference, Chicago, USA, 5-9 March, 2003.
Drosophila researchers have capitalized on the genome
sequence in the three years since it was released. From iden-
tifying paralogs and orthologs to microarray analysis of spe-
cific cell types, it is clear that the genome sequence is
changing approaches to Drosophila research. In this review
of the 2003 Drosophila research conference, I have focused
on talks illustrating the various ways in which the genome
sequence is being used.
The Larry Sandler Award is presented annually to the gradu-
ate student with the best thesis that uses Drosophila as a
model system. This year’s recipient, Sinisa Urban (Univer-
sity of Cambridge, UK), gave perhaps the best presentation
of the meeting. His thesis focused on how the cell controls
the release of the Spitz epidermal growth factor (EGF)
signal. In Drosophila, a single EGF receptor is used repeat-
edly in over 60 different contexts; control of how the signal
is released is therefore critical. Spitz is a transmembrane
protein, which must be cleaved by a protease to release the
signaling portion for secretion. Firstly, Urban presented bio-
chemical data showing that cleavage of the Spitz protein by
Rhomboid occurs in the Golgi apparatus and is followed by
glycosylation and secretion of the Spitz signaling portion.
Secondly, using biochemical and mutagenic approaches, he
demonstrated that Rhomboid is a serine protease: it con-
tains the residues necessary for serine protease catalysis,
and is inhibited by known serine protease inhibitors. He also
identified a family of seven Rhomboid-like proteins in
Drosophila and additional Rhomboid-like proteins in species
as diverse as the Gram-negative bacteria Pseudomonas
aeruginosa and  Providencia stuartii. Finally, he discussed
the cleavage site in the Spitz protein: a seven-amino-acid
sequence, ASIASGA in the single-letter amino-acid code, in a
transmembrane region of the Spitz protein. This motif is also
present in the TGF and Delta signaling proteins, suggesting
they may also be substrates for Rhomboid cleavage. The
ASIASGA motif seems to have two functions that allow it
to be cleaved by Rhomboid: it produces a kink in the
transmembrane  helix and it forms a hydrophilic pocket at
the top of the helix allowing water, which is necessary for
protease activity, to enter the cleavage site.
Michelle Markstein (University of California, Berkeley,
USA) used a computational method (Fly Enhancer
[http://flyenhancer.org]) to search the genome sequence
for clusters of enhancers that are targets of the Dorsal tran-
scription factor. Looking for clusters of enhancer sequences
appears to improve the sensitivity of such methods and has
allowed the identification of approximately one third of the
genes estimated to be directly affected by Dorsal. Besides
known targets such as zen, sog and brinker, she found novel
targets, including Phm, Ady and CG12443; these were con-
firmed by embryonic in situ hybridization and expression of
lacZ under the control of the putative enhancer. Interest-
ingly, it seems that clusters of different enhancer binding
sequences may be more diagnostic for the identification of
cis-control regions than clusters of a single binding site. 
A number of groups described research using microarray
analysis. Ulrike Gaul (Rockefeller University, New York,
USA) presented an analysis of glial cell transcription. Glial
cells labeled with green fluorescent protein under the control
of the repo promoter were chemically dissociated from
embryos and sorted by fluorescence-activated cell sorting
(FACS). Gene expression in glial and non-glial cell fractions
was assessed using an Affymetrix gene array, and 255
strongly expressed genes were identified. CG11910 is
expressed only in midline and longitudinal glia; reduction of
the transcript level by RNA interference (RNAi) prevents
midline glial cells from separating axon tracks in embryoniccommissures. Other examples of new genes found in this
screen include molecules affecting axon guidance, cell
migration and shape, and axon wrapping. The combination
of microarray analysis and RNAi provides a new paradigm
for rapid screening. 
Amir Orian (Fred Hutchinson Cancer Center, Seattle, USA)
has investigated the binding sites of the Myc-Max-Mad
(MMM) transcription factor complex. Fusions of Dam
methylase to these proteins were introduced into transgenic
flies, then genomic DNA was digested with a methylation-
sensitive restriction enzyme and the fragments were ana-
lyzed on a microarray. Interestingly, methylation of genes
encoding synaptic-vesicle and mitochondrial proteins was
observed, suggesting that the MMM complex may exert pre-
viously unknown influences on these processes. 
Greg Gibson (North Carolina State University, Raleigh, USA)
used long-oligonucleotide arrays to study the inheritance of
gene expression. Gene expression was measured in seven
strains of D. melanogaster and all F1 progeny of crosses
between those strains. His data show that approximately
10% of genes are differentially expressed between any two of
the strains studied, and that 20% of genes are expressed dif-
ferently in the F1 compared to the parental strains. It is pos-
sible to divide these differences into several classes: some
are expected, such as additive, dominant and recessive pat-
terns of inheritance of the expression level; in other cases,
the level of gene expression in the F1 is significantly greater
or less than can be explained by additive expression of both
parental strains. 
Many researchers are making use of the expanding
Drosophila gene collection. Mark Stapleton (Lawrence
Berkeley National Laboratory, Berkeley, USA) identified
RNA-editing substrates by comparing the high-quality cDNA
and genomic sequences. He found 27 adenosine deaminase
substrates, the majority of which are ion-channel tran-
scripts. Pavel Tomancak (University of California, Berkeley,
USA) presented a comparison of D. melanogaster and
D. pseudoobscura embryonic expression patterns for a
number of genes. The vast majority of the 176 genes investi-
gated showed identical expression patterns in the two
species. But two genes with different expression patterns
were identified. The expression of the midline fasciclin tran-
script is moved from the neuroectoderm in D. melanogaster
to the mesoderm in D. pseudoobscura. Ecdysone-inducible
gene E2 (described in a poster presented by Amy Beaton,
University of California, Berkeley, USA) is expressed in the
anterior of early embryos and in the developing foregut by
stage 11 in D. melanogaster, but in D. pseudoobscura it is
expressed in the posterior of early embryos and in the devel-
oping hindgut by stage 11.
Laura Lee (Massachusetts Institute of Technology, Cambridge,
USA) identified seven novel substrates for Pan gu, a protein
kinase required early in the cell cycle during embryogenesis.
Her biochemical screen made use of coupled transcription-
translation of cDNA clones from the Drosophila gene collec-
tion to produce [35S]-labeled proteins in a 384-well format.
Pools of 24 proteins were then screened in a variety of
binding, degradation and enzymatic assays. Examples
include screens for Disheveled-binding proteins, micro-
tubule-binding proteins and the Pan gu kinase assay based
on band shifts on electrophoretic gels.
One talk highlighted the imprecise art of gene prediction.
Marc Hild (University of Heidelberg, Germany) presented a
microarray constructed using a less stringent gene-predic-
tion program and a possible 21,396 putative ORFs. Expres-
sion data aquired using this array suggests that there are
3,000 more Drosophila genes than were predicted in the
Release 3 version of the genome.  Some of these sequences
produce phenotypes in S2 tissue culture cells when inhibited
by RNAi. Once the data are made public and analyzed in
detail, many of these ‘novel’ genes will no doubt be found to
have exons that overlap those of previous predictions. Other
differences may be ‘philosophical’: for example, should a
gene prediction be considered if it has an open reading
frame of less than 100 amino acids? It is clear that biological
evidence is required to positively identify a gene.
The  D. pseudoobscura sequence, available from the
Drosophila Genome Project [http://hgsc.bcm.tmc.edu/
projects/drosophila], may be the surest way to identify the
meaningful sequences of the D. melanogaster genome.
Richard Gibbs (Baylor College of Medicine, Houston, USA)
presented the initial release of the D. pseudoobscura
sequence. A tBLASTn comparison of the two Drosophila
genomes identified putative orthologs in D. pseudoobscura
for 95% of D. melanogaster  genes. Alignment of the two
genomic sequences identified both large features, such as
chromosomal inversions, and small ones, such as conserved
non-coding regions. A comparative genomic approach using
both sequences will improve gene prediction and allow the
identification of cis-regulatory sequences for the majority of
Drosophila genes. We can hope that the sequence of
D. pseudoobscura will be as informative to Drosophila
research as that of D. melanogaster, and many presenta-
tions on ‘the other Drosophila’ can be expected at future
annual conferences.
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